tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gregory Renza, 323 are a BUY (84.11%), 61 are a HOLD (15.89%).
Analyst Gregory Renza, currently employed at TRUIST, carries an average stock price target met ratio of 50.35% that have a potential upside of 46.26% achieved within 190 days. Previously, Gregory Renza worked at RBC.
Gregory Renza’s has documented 737 price targets and ratings displayed on 44 stocks. The coverage is on Healthcare, Consumer Defensive sectors.
Most recent stock forecast was given on JAZZ, Jazz Pharmaceuticals PLC at 26-Aug-2026.
Analyst best performing recommendations are on RXDX (PROMETHEUS BIOSCIENCES).
The best stock recommendation documented was for RXDX (PROMETHEUS BIOSCIENCES) at 12/7/2022. The price target of $111 was fulfilled within 1 day with a profit of $15.2 (15.87%) receiving and performance score of 158.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 07-Mar-2025
$28
$-0.02 (-0.07%)
Buy Since 21-Oct-2025
$40
$11.98 (42.76%)
$39
Buy Since 25-Sep-2025
$38
$9.98 (35.62%)
$29
Buy Since 17-Oct-2023
$49
$20.98 (74.88%)
$40
Buy Since 28-Feb-2024
$41
$12.98 (46.32%)
$29
Which stock is Gregory Renza is most bullish on?
Which stock is Gregory Renza is most reserved on?
What Year was the first public recommendation made by Gregory Renza?
